Linked Life Data

5449122

Source:http://linkedlifedata.com/resource/pubmed/id/5449122

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1970-9-28
pubmed:abstractText
1. Transient and steady-state changes caused by acetate utilization were studied in perfused rat heart. The transient period occupied 6min and steady-state changes were followed in a further 6min of perfusion. 2. In control perfusions glucose oxidation accounted for 75% of oxygen utilization; the remaining 25% was assumed to represent oxidation of glyceride fatty acids. With acetate in the steady state, acetate oxidation accounted for 80% of oxygen utilization, which increased by 20%; glucose oxidation was almost totally suppressed. The rate of tricarboxylate-cycle turnover increased by 67% with acetate perfusion. The net yield of ATP in the steady state was not altered by acetate. 3. Acetate oxidation increased muscle concentrations of acetyl-CoA, citrate, isocitrate, 2-oxoglutarate, glutamate, alanine, AMP and glucose 6-phosphate, and lowered those of CoA and aspartate; the concentrations of pyruvate, ATP and ADP showed no detectable change. The times for maximum changes were 1min, acetyl-CoA, CoA, alanine and AMP; 6min, citrate, isocitrate, glutamate and aspartate; 2-4min, 2-oxoglutarate. Malate concentration fell in the first minute and rose to a value somewhat greater than in the control by 6min. There was a transient and rapid rise in glucose 6-phosphate concentration in the first minute superimposed on the slower rise over 6min. 4. Acetate perfusion decreased the output of lactate, the muscle concentration of lactate and the [lactate]/[pyruvate] ratio in perfusion medium and muscle in the first minute; these returned to control values by 6min. 5. During the first minute acetate decreased oxygen consumption and lowered the net yield of ATP by 30% without any significant change in muscle ATP or ADP concentrations. 6. The specific radioactivities of cycle metabolites were measured during and after a 1min pulse of [1-(14)C]acetate delivered in the first and twelfth minutes of acetate perfusion. A model based on the known flow rates and concentrations of cycle metabolites was analysed by computer simulation. The model, which assumed single pools of cycle metabolites, fitted the data well with the inclusion of an isotope-exchange reaction between isocitrate and 2-oxoglutarate+bicarbonate. The exchange was verified by perfusions with [(14)C]bicarbonate. There was no evidence for isotope exchange between citrate and acetyl-CoA or between 2-oxoglutarate and malate. There was rapid isotope equilibration between 2-oxoglutarate and glutamate, but relatively poor isotope equilibration between malate and aspartate. 7. It is concluded that the citrate synthase reaction is displaced from equilibrium in rat heart, that isocitrate dehydrogenase and aconitate hydratase may approximate to equilibrium, that alanine aminotransferase is close to equilibrium, but that aspartate transamination is slow for reasons that have yet to be investigated. 8. The slow rise in citrate concentration as compared with the rapid rise in that of acetyl-CoA is attributed to the slow generation of oxaloacetate by aspartate aminotransferase. 9. It is proposed that the tricarboxylate cycle may operate as two spans: acetyl-CoA-->2-oxoglutarate, controlled by citrate synthase, and 2-oxoglutarate-->oxaloacetate, controlled by 2-oxoglutarate dehydrogenase; a scheme for cycle control during acetate oxidation is outlined. The initiating factors are considered to be changes in acetyl-CoA, CoA and AMP concentrations brought about by acetyl-CoA synthetase. 10. Evidence is presented for a transient inhibition of phosphofructokinase during the first minute of acetate perfusion that was not due to a rise in whole-tissue citrate concentration. The probable importance of metabolite compartmentation is stressed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-12981117, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-13058836, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14018085, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14070328, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14073034, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14304831, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14458636, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14479349, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-14803461, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-16742571, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-16749169, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4220951, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4220952, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4248332, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4284466, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4291039, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-4380667, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5246543, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5334625, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5449123, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5774512, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5839199, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5912101, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-5965976, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-6048783, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-6048784, http://linkedlifedata.com/resource/pubmed/commentcorrection/5449122-6048792
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
677-95
pubmed:dateRevised
2010-9-13
pubmed:meshHeading
pubmed:year
1970
pubmed:articleTitle
Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart.
pubmed:publicationType
Journal Article, In Vitro